Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiedu Xiefei Tongluo Recipe is a Traditional Chinese Medicine (TCM) formula developed by LongHua Hospital, Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of severe pneumonia and associated complications, such as myocardial injury. The formula is designed to clear heat, detoxify, drain the lungs, and unblock collaterals. Research, including network pharmacology and clinical biomarker studies, suggests that the recipe exerts its therapeutic effects by mitigating systemic inflammatory responses (cytokine storms) and protecting against oxidative stress. It has been specifically investigated for its efficacy in treating severe viral pneumonia, including cases related to COVID-19, where it has shown potential in reducing levels of cardiac injury markers like Troponin I and NT-proBNP, as well as pro-inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiedu Xiefei Tongluo Recipe.